Filing Details

Accession Number:
0001104659-25-034321
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-04-11 21:57:19
Reporting Period:
2025-04-09
Filing Date:
2025-04-11
Accepted Time:
2025-04-11 21:57:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1664710 Keros Therapeutics Inc. KROS Pharmaceutical Preparations (2834) 811173868
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1758866 Adar1 Partners, Lp 3503 Wild Cherry Drive
Building 9
Austin TX 78738
No No Yes No
1861120 Daniel Schneeberger 3503 Wild Cherry Drive
Building 9
Austin TX 78738
No No Yes No
1940267 Adar1 Capital Management Gp, Llc 3503 Wild Cherry Drive
Building 9
Austin TX 78738
No No Yes No
1940272 Adar1 Capital Management, Llc 3503 Wild Cherry Drive
Building 9
Austin TX 78738
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-04-09 18,560 $9.40 3,493,404 No 4 P Indirect By ADAR1 Partners, LP
Common Stock Acquisiton 2025-04-09 16,365 $9.40 743,558 No 4 P Indirect By Spearhead Insurance Solutions IDF, LLC
Common Stock Acquisiton 2025-04-09 325,000 $9.86 3,818,404 Yes 4 P Indirect By ADAR1 Partners, LP
Common Stock Acquisiton 2025-04-09 500,000 $10.33 4,318,404 Yes 4 P Indirect By ADAR1 Partners, LP
Common Stock Acquisiton 2025-04-09 74,333 $10.33 4,392,737 Yes 4 P Indirect By ADAR1 Partners, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By ADAR1 Partners, LP
No 4 P Indirect By Spearhead Insurance Solutions IDF, LLC
Yes 4 P Indirect By ADAR1 Partners, LP
Yes 4 P Indirect By ADAR1 Partners, LP
Yes 4 P Indirect By ADAR1 Partners, LP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Cash-Settled Total Return Swaps Disposition 2025-04-09 325,000 $0.00 325,000 $0.00
Common Stock Cash-Settled Total Return Swaps Disposition 2025-04-09 500,000 $0.00 500,000 $0.00
Common Stock Cash Settled Total Return Swaps Disposition 2025-04-09 74,333 $0.00 74,333 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
624,333 No 4 J Indirect
124,333 No 4 J Indirect
50,000 No 4 J Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 254,669 Indirect By ADAR1 SPV I, LP
Footnotes
  1. As the investment manager of ADAR1 Partners, LP and ADAR1 SPV I, LP and as the sub-advisor of Spearhead Insurance Solutions IDF, LLC, ADAR1 Capital Management, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP, ADAR1 SPV I, LP and Spearhead Insurance Solutions IDF, LLC. As the general partner of ADAR1 Partners, LP and ADAR1 SPV I, LP, ADAR1 Capital Management GP, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and ADAR1 SPV I, LP. As the manager of ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, Mr. Schneeberger may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP, Spearhead Insurance Solutions IDF, LLC, and ADAR1 SPV I, LP.
  2. The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.21 to $9.56, inclusive.
  3. The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.21 to $9.56, inclusive.
  4. The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.13 to $10.60, inclusive.
  5. In connection with the purchase of 325,000 securities reported as being purchased in Table 1, ADAR1 Partners, LP and the counterparty to the cash-settled total equity swaps previously reported agreed to reduce the number of notional shares of Common Stock of the Issuer in the applicable basket by a corresponding number of 325,000 shares. As a result, the aggregate number of notional shares of Common Stock of the Issuer in the applicable basket after giving effect to such transactions is 624,333 shares.
  6. In connection with the purchase of 500,000 securities reported as being purchased in Table 1, ADAR1 Partners, LP and the counterparty to the cash-settled total equity swaps previously reported agreed to reduce the number of notional shares of Common Stock of the Issuer in the applicable basket by a corresponding number of 500,000 shares. As a result, the aggregate number of notional shares of Common Stock of the Issuer in the applicable basket after giving effect to such transactions is 124,333 shares.
  7. In connection with the purchase of 74,333 securities reported as being purchased in Table 1, ADAR1 Partners, LP and the counterparty to the cash-settled total equity swaps previously reported agreed to reduce the number of notional shares of Common Stock of the Issuer in the applicable basket by a corresponding number of 74,333 shares. As a result, the aggregate number of notional shares of Common Stock of the Issuer in the applicable basket after giving effect to such transactions is 50,000 shares.
  8. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.